Telomerase peptide vaccination in NSCLC: a phase II trial in stage III patients vaccinated after chemoradiotherapy and an 8-year update on a phase I/II trial. (Q50992560)
Jump to navigation
Jump to search
scientific article published on 14 September 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Telomerase peptide vaccination in NSCLC: a phase II trial in stage III patients vaccinated after chemoradiotherapy and an 8-year update on a phase I/II trial. |
scientific article published on 14 September 2011 |
Statements
1 reference
Telomerase peptide vaccination in NSCLC: a phase II trial in stage III patients vaccinated after chemoradiotherapy and an 8-year update on a phase I/II trial. (English)
1 reference
Gustav Gaudernack
1 reference
Paal Fr Brunsvig
1 reference
Jon Amund Kyte
1 reference
Christian Kersten
1 reference
Stein Sundstrøm
1 reference
Mona Møller
1 reference
Marta Nyakas
1 reference
Gaute L Hansen
1 reference
Steinar Aamdal
1 reference
14 September 2011
1 reference
17
1 reference
6847-6857
1 reference
21
1 reference
Identifiers
1 reference